Ketamine Therapy in Indiana

Indiana follows federal guidelines established by the Drug Enforcement Administration (DEA) and the Food and Drug Administration (FDA) for the clinical use of ketamine. As a Schedule III controlled substance under the Controlled Substances Act, ketamine may be legally administered in clinical settings by licensed medical professionals for approved and off-label therapeutic purposes. Clinics operating in Indiana must maintain DEA registration, adhere to strict controlled substance storage and dispensing protocols, and ensure that all ketamine infusions are administered under the direct supervision of a qualified physician or advanced practice provider.

At the state level, ketamine therapy practices in Indiana are overseen by the Indiana Professional Licensing Agency (IPLA) and the relevant licensing boards, including the Indiana Medical Licensing Board and the Indiana State Board of Nursing. Physicians, nurse practitioners, and certified registered nurse anesthetists (CRNAs) who administer or supervise ketamine treatments must hold active, unrestricted licenses in good standing with the state. Clinics are also subject to applicable facility regulations, and providers must comply with Indiana's controlled substance prescribing and recordkeeping requirements as outlined under Indiana Code Title 35, Article 48.

It is important for patients to understand the distinction between IV ketamine infusions and esketamine (Spravato), the FDA-approved nasal spray for treatment-resistant depression. Spravato carries specific FDA Risk Evaluation and Mitigation Strategy (REMS) requirements, mandating that it be administered only in certified healthcare settings with a minimum two-hour observation period. Off-label IV ketamine infusions, while widely used clinically, are not covered by most insurance plans in Indiana, meaning patients typically bear out-of-pocket costs. Prospective patients are encouraged to verify a clinic's credentials, confirm provider licensure through the IPLA, and consult with their primary care or mental health provider before beginning treatment.